Yen K, Wan J, Mehta HH et al (2018) Humanin prevents age-related cognitive decline in mice and is associated with improved cognitive age in humans
A typical transition timeline might look like this: Weeks 1-4: Start tirzepatide 2.5 mg weekly while maintaining phentermine at current dose Weeks 5-8: Increase tirzepatide to 5 mg weekly, reduce phentermine to 15 mg daily (if currently on a higher dose) Weeks 9-12: Increase tirzepatide to 7.5 mg weekly, begin tapering phentermine to every other day Week 13+: Discontinue phentermine, continue tirzepatide titration as needed This is a general framework, not a prescription
Reported side effects are typically mild and transient
Common barriers such as food cravings and ineffective weight loss treatments hinder residents in achieving significant weight loss
At 130+ degrees, significant degradation can occur within minutes, not hours
The Often-Ignored Risk of Rapid Weight Loss: Muscle Loss According to Dr